The Newsroom
AdventHealth Among First in U.S. to Offer IDP023-2-101 Clinical Trial for Patients with Progressive Multiple Sclerosis
The AdventHealth Neuroscience Institute is the first in Florida and one of the first in the country to begin recruiting patients with primary progressive or non-active secondary progressive multiple...
AdventHealth Research Contributed to New Method for Tracking Diet and Its Impacts on Human Health
Mayor Demings, AdventHealth on bridging health care gaps
Recent Stories at AdventHealthMD
-
-
New State-of-the-Art Cellular Therapy Facility Opening at AdventHealth Orlando
-
Genetic Testing at AdventHealth Alerts Woman, Doctors to Aggressive Cancer Before it Develops
-
AdventHealth Clinical Research Unit Recruiting Patients with Solid Tumors Harboring MTAP Deletion for Phase I Clinical Trial
-
New England Journal of Medicine highlights Guru Sonpavde, MD’s work in new immunotherapy-chemotherapy combination improving survival for patients with advanced urothelial carcinoma
-
AdventHealth physicians explain Post-COVID Clinic model and first year research findings during American Hospital Association podcast